GH1 and neoplasm: Other suggested complication includes the development of new primary cancers but long-term studies did not confirm an increased prevalence or recurrence of the primary tumour after GH replacement therapy, and the occurrence of new tumours, if it occurs, appears to be very rare [53,54,55].